Pharmasyntez-Tyumen LLC, which is a part of the Pharmasyntez Group of Companies, has recently enhanced its product assortment by introducing PlaniZhens Chloe, an innovative oral contraceptive. The medication has made its way after being officially registered in the spring of 2023.
“For a long period, the market for hormonal drugs in Russia was represented mainly by foreign manufacturers. Realizing the importance of import substitution of medicines and the problems of national drug safety, our company is actively developing its own production of hormonal drugs, including contraceptives,” noted Vladimir Ivanovich Kisilenko, General Director of Pharmasyntez-Tyumen LLC.
